HAIXI PHARMA

2637
145.0000.83% ( +1.200 )
Delay Trading: Nov 17, 11:09:25

Valuation

Current ValuationThe current P/E ratio is 65.42, within the reasonable range, cheaper than 63.6% of the time in the past 1 years, and the industry ranks 31/53, the industry Median 6.94.

65.42xP/E
Stock priceHK$143.80Earnings per shareHK$2.20

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
017345168

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
02637HKHAIXI PHARMA
65.42x6.78%HK$11.32B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.